Inflammatory mediators and fibroblast markers

Inflammatory mediators and fibroblast markers refer to a heterogeneous group of signaling molecules and cellular proteins that drive the inflammatory response and tissue remodeling processes. Inflammatory mediators include a wide array of cytokines, chemokines, and lipid mediators (e.g., prostaglandins) that coordinate the recruitment and activation of leukocytes (PubMed: 29485209). Fibroblast markers, such as alpha-smooth muscle actin (α-SMA) and vimentin, are typically used to identify fibroblasts and myofibroblasts, which are the primary cells responsible for extracellular matrix production during wound healing and fibrosis (PubMed: 28117445). While individual components within this group, such as TNF-alpha or IL-6, are validated therapeutic targets, the collective term itself represents a broad biological category rather than a single druggable entity. Dysregulation of these markers is a hallmark of chronic inflammatory diseases, organ fibrosis, and the tumor microenvironment, making them critical for diagnostic and prognostic assessments in clinical settings.

Other names

Inflammatory cytokinesFibrotic markersPro-inflammatory mediatorsMyofibroblast markersInflammatory and fibrotic signaling molecules

Not applicable as this is a collective term for multiple distinct molecules rather than a single drug target.